These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15097858)

  • 21. Epidermal growth factor receptor blockade by antibody IMC-C225 inhibits growth of a human pancreatic carcinoma xenograft in nude mice.
    Overholser JP; Prewett MC; Hooper AT; Waksal HW; Hicklin DJ
    Cancer; 2000 Jul; 89(1):74-82. PubMed ID: 10897003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo.
    Harima H; Kaino S; Takami T; Shinoda S; Matsumoto T; Fujisawa K; Yamamoto N; Yamasaki T; Sakaida I
    BMC Cancer; 2016 Aug; 16(1):702. PubMed ID: 27582255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rottlerin suppresses growth of human pancreatic tumors in nude mice, and pancreatic cancer cells isolated from Kras(G12D) mice.
    Huang M; Tang SN; Upadhyay G; Marsh JL; Jackman CP; Srivastava RK; Shankar S
    Cancer Lett; 2014 Oct; 353(1):32-40. PubMed ID: 25050737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The novel hypoxic cytotoxin, TX-2098 has antitumor effect in pancreatic cancer; possible mechanism through inhibiting VEGF and hypoxia inducible factor-1α targeted gene expression.
    Miyake K; Nishioka M; Imura S; Batmunkh E; Uto Y; Nagasawa H; Hori H; Shimada M
    Exp Cell Res; 2012 Aug; 318(13):1554-63. PubMed ID: 22472348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subdiaphragmatic vagotomy promotes tumor growth and reduces survival via TNFα in a murine pancreatic cancer model.
    Partecke LI; Käding A; Trung DN; Diedrich S; Sendler M; Weiss F; Kühn JP; Mayerle J; Beyer K; von Bernstorff W; Heidecke CD; Keßler W
    Oncotarget; 2017 Apr; 8(14):22501-22512. PubMed ID: 28160574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The neurotrophin-trk receptor axes are critical for the growth and progression of human prostatic carcinoma and pancreatic ductal adenocarcinoma xenografts in nude mice.
    Miknyoczki SJ; Wan W; Chang H; Dobrzanski P; Ruggeri BA; Dionne CA; Buchkovich K
    Clin Cancer Res; 2002 Jun; 8(6):1924-31. PubMed ID: 12060637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effects of epidermal growth factor and its antibody on the growth of xenografts in athymic nude mice].
    Zeng CX; Liu TH; Chen J
    Zhonghua Bing Li Xue Za Zhi; 1994 Aug; 23(4):215-7. PubMed ID: 7805149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activated epidermal growth factor receptor as a novel target in pancreatic cancer therapy.
    Harsha HC; Jimeno A; Molina H; Mihalas AB; Goggins MG; Hruban RH; Schulick RD; Kamath U; Maitra A; Hidalgo M; Pandey A
    J Proteome Res; 2008 Nov; 7(11):4651-8. PubMed ID: 18821783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined inhibition of PAK7, MAP3K7 and CK2alpha kinases inhibits the growth of MiaPaCa2 pancreatic cancer cell xenografts.
    Giroux V; Iovanna JL; Garcia S; Dagorn JC
    Cancer Gene Ther; 2009 Sep; 16(9):731-40. PubMed ID: 19363471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation.
    Rowland-Goldsmith MA; Maruyama H; Kusama T; Ralli S; Korc M
    Clin Cancer Res; 2001 Sep; 7(9):2931-40. PubMed ID: 11555612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice.
    Saimura M; Nagai E; Mizumoto K; Maehara N; Okino H; Katano M; Matsumoto K; Nakamura T; Narumi K; Nukiwa T; Tanaka M
    Cancer Gene Ther; 2002 Oct; 9(10):799-806. PubMed ID: 12224019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of liposomal curcumin in a human pancreatic tumor xenograft model: inhibition of tumor growth and angiogenesis.
    Ranjan AP; Mukerjee A; Helson L; Gupta R; Vishwanatha JK
    Anticancer Res; 2013 Sep; 33(9):3603-9. PubMed ID: 24023285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene therapy for pancreatic cancer using an adenovirus vector encoding soluble flt-1 vascular endothelial growth factor receptor.
    Hoshida T; Sunamura M; Duda DG; Egawa S; Miyazaki S; Shineha R; Hamada H; Ohtani H; Satomi S; Matsuno S
    Pancreas; 2002 Aug; 25(2):111-21. PubMed ID: 12142732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Yarrowia lipolytica Lipase 2 Is Stable and Highly Active in Test Meals and Increases Fat Absorption in an Animal Model of Pancreatic Exocrine Insufficiency.
    Aloulou A; Schué M; Puccinelli D; Milano S; Delchambre C; Leblond Y; Laugier R; Carrière F
    Gastroenterology; 2015 Dec; 149(7):1910-1919.e5. PubMed ID: 26327131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experimental study of MAT1 gene silencing mediated by siRNA in pancreatic cancer].
    Liu JP; Yuan SZ; Zhang SN
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2719-23. PubMed ID: 18167254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of the expression of Wnt5a promotes the proliferation of pancreatic cancer cells in vitro and in a nude mouse model.
    Bo H; Gao L; Chen Y; Zhang J; Zhu M
    Mol Med Rep; 2016 Feb; 13(2):1163-71. PubMed ID: 26648282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Irreversible electroporation shows efficacy against pancreatic carcinoma without systemic toxicity in mouse models.
    José A; Sobrevals L; Ivorra A; Fillat C
    Cancer Lett; 2012 Apr; 317(1):16-23. PubMed ID: 22079741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
    Yang Y; Tao X; Li CB; Wang CM
    Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transforming growth factor-alpha and epidermal growth factor expression in the exocrine pancreas of azaserine-treated rats: modulation by cholecystokinin or a low fat, high fiber (caloric restricted) diet.
    Visser CJ; Woutersen RA; Bruggink AH; van Garderen-Hoetmer A; Seifert-Bock I; Tilanus MG; de Weger RA
    Carcinogenesis; 1995 Sep; 16(9):2075-82. PubMed ID: 7554057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.